vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and RANGE RESOURCES CORP (RRC). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $786.9M, roughly 1.4× RANGE RESOURCES CORP). RANGE RESOURCES CORP runs the higher net margin — 22.8% vs -127.8%, a 150.6% gap on every dollar of revenue. On growth, RANGE RESOURCES CORP posted the faster year-over-year revenue change (18.0% vs -2.5%). Over the past eight quarters, RANGE RESOURCES CORP's revenue compounded faster (14.6% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Range Resources Corporation is a natural gas exploration and production company, the headquartered is in Fort Worth, Texas. It operates in the Marcellus Formation, where it is the largest land owners.
PRGO vs RRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $786.9M |
| Net Profit | $-1.4B | $179.1M |
| Gross Margin | 32.6% | 94.5% |
| Operating Margin | -116.0% | — |
| Net Margin | -127.8% | 22.8% |
| Revenue YoY | -2.5% | 18.0% |
| Net Profit YoY | -3093.9% | 88.8% |
| EPS (diluted) | $-10.23 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $786.9M | ||
| Q3 25 | $1.0B | $655.3M | ||
| Q2 25 | $1.1B | $699.6M | ||
| Q1 25 | $1.0B | $846.3M | ||
| Q4 24 | $1.1B | $667.0M | ||
| Q3 24 | $1.1B | $567.9M | ||
| Q2 24 | $1.1B | $513.2M | ||
| Q1 24 | $1.1B | $598.8M |
| Q4 25 | $-1.4B | $179.1M | ||
| Q3 25 | $7.5M | $144.3M | ||
| Q2 25 | $-8.4M | $237.6M | ||
| Q1 25 | $-6.4M | $97.1M | ||
| Q4 24 | $-44.4M | $94.8M | ||
| Q3 24 | $-21.0M | $50.7M | ||
| Q2 24 | $-108.4M | $28.7M | ||
| Q1 24 | $2.0M | $92.1M |
| Q4 25 | 32.6% | 94.5% | ||
| Q3 25 | 36.1% | 92.5% | ||
| Q2 25 | 34.4% | 95.0% | ||
| Q1 25 | 37.6% | 93.1% | ||
| Q4 24 | 33.9% | 93.7% | ||
| Q3 24 | 37.2% | 94.3% | ||
| Q2 24 | 37.0% | 93.4% | ||
| Q1 24 | 33.1% | 94.7% |
| Q4 25 | -116.0% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | 7.4% | — | ||
| Q2 24 | -2.5% | — | ||
| Q1 24 | -5.1% | — |
| Q4 25 | -127.8% | 22.8% | ||
| Q3 25 | 0.7% | 22.0% | ||
| Q2 25 | -0.8% | 34.0% | ||
| Q1 25 | -0.6% | 11.5% | ||
| Q4 24 | -3.9% | 14.2% | ||
| Q3 24 | -1.9% | 8.9% | ||
| Q2 24 | -10.2% | 5.6% | ||
| Q1 24 | 0.2% | 15.4% |
| Q4 25 | $-10.23 | $0.75 | ||
| Q3 25 | $0.05 | $0.60 | ||
| Q2 25 | $-0.06 | $0.99 | ||
| Q1 25 | $-0.05 | $0.40 | ||
| Q4 24 | $-0.32 | $0.38 | ||
| Q3 24 | $-0.15 | $0.21 | ||
| Q2 24 | $-0.79 | $0.12 | ||
| Q1 24 | $0.01 | $0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $204.0K |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $2.9B | $4.3B |
| Total Assets | $8.5B | $7.4B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $204.0K | ||
| Q3 25 | $432.1M | $175.0K | ||
| Q2 25 | $454.2M | $134.0K | ||
| Q1 25 | $409.9M | $344.6M | ||
| Q4 24 | $558.8M | $304.5M | ||
| Q3 24 | $1.5B | $277.4M | ||
| Q2 24 | $542.8M | $251.1M | ||
| Q1 24 | $658.5M | $343.1M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
| Q4 25 | $2.9B | $4.3B | ||
| Q3 25 | $4.4B | $4.2B | ||
| Q2 25 | $4.5B | $4.1B | ||
| Q1 25 | $4.4B | $3.9B | ||
| Q4 24 | $4.3B | $3.9B | ||
| Q3 24 | $4.6B | $3.9B | ||
| Q2 24 | $4.5B | $3.9B | ||
| Q1 24 | $4.7B | $3.8B |
| Q4 25 | $8.5B | $7.4B | ||
| Q3 25 | $10.1B | $7.2B | ||
| Q2 25 | $10.1B | $7.1B | ||
| Q1 25 | $9.8B | $7.4B | ||
| Q4 24 | $9.6B | $7.3B | ||
| Q3 24 | $11.2B | $7.2B | ||
| Q2 24 | $10.4B | $7.3B | ||
| Q1 24 | $10.6B | $7.4B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $257.5M |
| Free Cash FlowOCF − Capex | $148.6M | — |
| FCF MarginFCF / Revenue | 13.4% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $257.5M | ||
| Q3 25 | $51.7M | $247.5M | ||
| Q2 25 | $75.9M | $336.2M | ||
| Q1 25 | $-64.5M | $330.1M | ||
| Q4 24 | $312.6M | $217.9M | ||
| Q3 24 | $42.2M | $245.9M | ||
| Q2 24 | $9.5M | $148.8M | ||
| Q1 24 | $-1.4M | $331.9M |
| Q4 25 | $148.6M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $56.7M | — | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $274.9M | — | ||
| Q3 24 | $15.1M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-26.5M | — |
| Q4 25 | 13.4% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -2.4% | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | — | 1.44× | ||
| Q3 25 | 6.89× | 1.72× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | -0.70× | 3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
